Cannabinoid receptors and the regulation of bone mass

British Journal of Pharmacology

Volumn 153, Issue 2, 2008, Pages 182-188

  Bab, I ^a   Zimmer, A ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Bone formation; Bone mass; Bone mineral density; Bone remodelling; Bone resorption; CB1 cannabinoid receptors; CB2 cannabinoid receptors; Endocannabinoids; Osteoporosis; Single nucleotide polymorphism

Indexed keywords

4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR;

BIOSYNTHESIS; BONE DENSITY; BONE MASS; BONE REMODELING; CNR2 GENE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; GENE; GENOTYPE; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CANNABINOIDS; HUMANS; ORGAN SIZE; OSTEOPOROSIS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID;

EID: 38349132542     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707593     Document Type: Review

References (83)

1. Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y et al. (2003). TSH is a negative regulator of skeletal remodeling. Cell 115: 151-162.
2. Alexander JM, Bab I, Fish S, Muller R, Uchiyama T, Gronowicz G et al. (2001). Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice. J Bone Miner Res 16: 1665-1673.
3. Amor A, Smith PA, t'Hart B, Baker D (2005). Biozzi mice: of mice and human neurological diseases. J Neuroimmunol 165: 1-10.
4. Araujo AM, Buschang PH, Melo AC (2004). Adaptive condylar growth and mandibular remodelling changes with bionator therapy - an implant study. Eur J Orthod 26: 515-522.
5. Bab I (2005). The skeleton: stone bones and stoned heads?. In: Mechoulam R (ed). Cannabinoids as Therapeutics Milestones in Drug Therapy Series. Birkhäuser Verlag: Basel.
6. Bab I, Ashton BA, Gazit D, Marx G, Williamson MC, Owen ME (1986). Kinetics and differentiation of marrow stromal cells in diffusion chambers in vivo. J Cell Sci 84: 139-151.
7. Bab I, Chorev M (2002). Osteogenic growth peptide: from concept to drug design. Biopolymers 66: 33-48.
8. Bab I, Hajbi-Yonissi C, Gabet Y, Müller R (2007). Micro-Tomographic Atlas of the Mouse Skeleton. Springer: New York. pp. 195-199.
9. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM et al. (2002). Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109: 915-921.
10. Bellows CG, Aubin JE, Heersche JN, Antosz ME (1986). Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38: 143-154.
11. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A et al. (2003). Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163: 463-468.
12. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ (1984). Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1: 1091-1093.
13. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C et al. (1998). Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12: 1260-1268.
14. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR et al. (2001). Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98: 9371-9376.
15. Derkinderen P, Ledent C, Parmentier M, Girault JA (2001). Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J Neurochem 77: 957-960.
16. Derkinderen P, Toutant M, Burgaya F, Le Bert M, Siciliano JC, de Franciscis V et al. (1996). Regulation of a neuronal form of focal adhesion kinase by anandamide. Science 273: 1719-1722.
17. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949.
18. Devoto M, Shimoya K, Caminis J, Ott J, Tenenhouse A, Whyte MP et al. (1998). First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet 6: 151-157.
19. Devoto M, Specchia C, Li HH, Caminis J, Tenenhouse A, Rodriguez H et al. (2001). Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. Hum Mol Genet 10: 2447-2452.
20. Devoto M, Spotila LD, Stabley DL, Wharton GN, Rydbeck H, Korkko J et al. (2005). Univariate and bivariate variance component linkage analysis of a whole-genome scan for loci contributing to bone mineral density. Eur J Hum Genet 13: 781-788.
21. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA et al. (1999). Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 264: 258-267.
22. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z et al. (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822-825.
23. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT et al. (2000). Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100: 197-207.
24. Gabet Y, Kohavi D, Muller R, Chorev M, Bab I (2005). Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats. Osteoporos Int 16: 1436-1443.
25. George KL, Saltman LH, Stein GS, Lian JB, Zurier RB (2007). Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells. J Cell Physiol; [e-pub ahead of print].
26. Gomez del Pulgar T, Velasco G, Guzman M (2000). The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J 347: 369-373.
27. Gunther T, Chen ZF, Kim J, Priemel M, Rueger JM, Amling M et al. (2000). Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature 406: 199-203.
28. Hansen HS, Moesgaard B, Hansen HH, Petersen G (2000). N-Acylethanolamines and precursor phospholipids - relation to cell injury. Chem Phys Lipids 108: 135-150.
29. Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE et al. (2001). 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA 98: 3662-3665.
30. Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M et al. (1999). HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci USA 96: 14228-14233.
31. Howlett AC (2002). The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68-69: 619-631.
32. Idris AI, van 't Hof RJ, Greig IR, Ridge SA, Baker D, Ross RA et al. (2005). Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med 11: 774-779.
33. Jorgensen NR, Henriksen Z, Sorensen OH, Civitelli R (2004). Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69: 219-226.
34. Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M et al. (2005). Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128: 742-755.
35. Karsak M, Cohen-Solal M, Freudenberg J, Ostertag A, Morieux C, Kornak U et al. (2005). Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet 14: 3389-3396.
36. Karsenty G (2001). Leptin controls bone formation through a hypothalamic relay. Recent Prog Horm Res 56: 401-415.
37. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C et al. (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
38. Konrad RJ, Major CD, Wolf BA (1994). Diacylglycerol hydrolysis to arachidonic acid is necessary for insulin secretion from isolated pancreatic islets: sequential actions of diacylglycerol and monoacylglycerol lipases. Biochemistry 33: 13284-13294.
39. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
40. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F et al. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401-404.
41. Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, van Wijnen AJ et al. (2004). Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14: 1-41.
42. Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A et al. (2000). Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 346 (Part 3): 835-840.
43. Manolagas SC (2000). Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21: 115-137.
44. McCaw E, Hu H, Gomez GT, Hebb AL, Kelly ME, Denovan-Wright EM (2004). Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice. Eur J Biochem 271: 4909-4920.
45. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR et al. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83-90.
46. Melck D, Rueda D, Galve-Roperh I, De Petrocellis L, Guzman M, Di Marzo V (1999). Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett 463: 235-240.
47. 2+ in endothelial cells. Br J Pharmacol 126: 1593-1600.
48. Most W, van der Wee-Pals L, Ederveen A, Papapoulos S, Lowik C (1997). Ovariectomy and orchidectomy induce a transient increase in the osteoclastogenic potential of bone marrow cells in the mouse. Bone 20: 27-30.
49. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FA, Martin TJ (1986). Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest 78: 355-360.
50. Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K et al. (2006). Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA 103: 696-701.
51. Orzel JA, Rudd TG (1985). Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl Med 26: 125-132.
52. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R et al. (2001). An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413: 527-531.
53. Parfitt AM (1982). The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. Metab Bone Dis Relat Res 4: 1-6.
54. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H et al. (1994). Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13: 1189-1196.
55. Potts JT, Juppner H (1998). Parathyroid Hormone and Parathyroid Hormone-related Peptidein Calcium Homeostasis, Bone Metabolism, and Bone Development: the Proteins, Their Genes, and Receptors. Academic Press: San Diego, CA.
56. Roodman GD (1999). Cell biology of the osteoclast. Exp Hematol 27: 1229-1241.
57. Rueda D, Galve-Roperh I, Haro A, Guzman M (2000). The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol 58: 814-820.
58. Scutt A, Williamson EM (2007). Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. Calcif Tissue Int 80: 50-59.
59. Segev E, Ofek O, Bajayo A, Gabet Y, Bab I (2006). Age- and gender-related variations in bone growth and structure: a mCT analysis in mice. J Bone Miner Res 21: S10.
60. Shire D, Calandra B, Bouaboula M, Barth F, Rinaldi-Carmona M, Casellas P et al. (1999). Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. Life Sci 65: 627-635.
61. Simon GM, Cravatt BF (2006). Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J Biol Chem 281: 26465-26472.
62. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R et al. (1997). Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
63. Steffens S, Veillard NR, Arnaud C, Pelli G, Burger F, Staub C et al. (2005). Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 434: 782-786.
64. Stella N, Schweitzer P, Piomelli D (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778.
65. Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N (2001). The molecular basis of osteoclast differentiation and activation. Novartis Found Symp 232: 235-247; discussion 247-250.
66. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S (1983). In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96: 191-198.
67. Sugiura T, Kobayashi Y, Oka S, Waku K (2002). Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids 66: 173-192.
68. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ et al. (2006). FSH directly regulates bone mass. Cell 125: 247-260.
69. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL et al. (2002). Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305-317.
70. Tam J, Ofek O, Fride E, Ledent C, Gabet Y, Muller R et al. (2006). Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol Pharmacol 70: 786-792.
71. Tam J, Trembovler V, Di Marzo V, Petrosino S, Leo G, Alexandrovich A et al. (2007). The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J; [e-pub ahead of print].
72. Varga K, Wagner JA, Bridgen DT, Kunos G (1998). Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12: 1035-1044.
73. Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ (1995). The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 359: 133-136.
74. Wildburger R, Zarkovic N, Tonkovic G, Skoric T, Frech S, Hartleb M et al. (1998). Post-traumatic hormonal disturbances: prolactin as a link between head injury and enhanced osteogenesis. J Endocrinol Invest 21: 78-86.
75. Willoughby KA, Moore SF, Martin BR, Ellis EF (1997). The biodisposition and metabolism of anandamide in mice. J Pharmacol Exp Ther 282: 243-247.
76. Wright K, Rooney N, Feeney M, Tate J, Robertson D, Welham M et al. (2005). Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 129: 437-453.
77. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL et al. (2002). Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110: 771-781.
78. Yamada Y, Ando F, Shimokata H (2007). Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int J Mol Med 19: 791-801.
79. Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N et al. (2000). Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103: 1085-1097.
80. Zhang P, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D et al. (2004). Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry 9: 916-931.
81. Zhang RW, Supowit SC, Xu X, Li H, Christensen MD, Lozano R et al. (1995). Expression of selected osteogenic markers in the fibroblast-like cells of rat marrow stroma. Calcif Tissue Int 56: 283-291.
82. Zhou H, Choong P, McCarthy R, Chou ST, Martin TJ, Ng KW (1994). In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J Bone Miner Res 9: 1489-1499.
83. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999). Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96: 5780-5785.